share_log

苑东生物(688513.SH):马来酸氟伏沙明片获得药品注册证书

chengdu easton biopharmaceuticals (688513.SH): The registration certificate of fluvoxamine maleate tablets for pharmaceutical has been obtained

Gelonghui Finance ·  Sep 2 06:05

Chengdu Easton Biopharmaceuticals (688513.SH) announced on September 2nd that its wholly-owned subsidiary Chengdu Shuode Pharmaceutical Co., Ltd. (referred to as "Shuode Pharmaceutical") recently received the "Pharmaceutical Registration Certificate" issued by the National Medical Products Administration for Fluvoxamine Maleate Tablets. The main ingredient of the tablets is fluvoxamine maleate, indicated for: (1) depression; (2) obsessive-compulsive disorder.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment